Timeslot: Friday, April 23, 2021 - 11:00am to 12:30pm
Track: Industry
Room: Virtual
About
B&MPC SIG members exchange ideas and experiences about the commercialization of medical products dependent upon biomaterials for utility and efficacy. Society for Biomaterials members, ranging from students to veterans in the field, will find an open forum to explore issues facing commercial biomaterials, such as regulations, patents, litigation, reimbursement for the resultant medical device, manufacturing and distribution; as well as perceptions of safety and patient benefits. Translation from development to marketing of safe and innovative medical products is challenged by the inconsistent availability of biomaterials in the shadow of these concerns, and a politically lively healthcare arena. Join the Biomaterials and Medical Products Commercialization SIG to enhance your knowledge and coping skills in the dynamic healthcare community.
Moderator:
Stephanie Steichen, PhD
Abstracts
Abstracts will be available for download on April 20, 2021.
Biomaterials Systems and Devices for Hemostasis, Resuscitation and Wound Care
Timeslot: Friday, April 23, 2021 - 11:00am to 12:30pm
Track: Cardiovascular Biomaterials
Room: Virtual
About
Hemorrhage control, hemodynamic resuscitation and spatio-temporal wound care via passive and/or bioactive mechanisms are important application areas of biomaterials-based technologies and includes external, intracavitary, and intravascular hemostats, nanoparticle/microparticle systems, artificial blood surrogates, dressings, powders, foams, fibers and gels. The goal of this session is to highlight recent advances in such biomaterials technologies that focus on hemostasis/thrombosis, hemodynamic stabilization, tissue oxygenation and wound healing. The proposed session will invite presentations from researchers in this field that discuss design of the biomaterials systems, structure-property-function relationships, and translational visions of such technologies. Presentations focused on material considerations for microdevices for investigating hemostatic and thrombotic pathways are also of interest for this session.
Moderators:
Ashley Brown, PhD
Shaunak Pandya, PhD
Abstracts
Abstracts will be available for download on April 20, 2021.
Engineered Biomaterials for Neural Applications 2
Timeslot: Friday, April 23, 2021 - 11:00am to 12:30pm
Track: Sensory Biomaterials and Tissues
Room: Virtual
About
Engineered biomaterials are uniquely positioned for use in creating, testing, and regenerating neural tissue with applications like in vitro models of injury and disease, therapeutic treatments, understanding neural development, and mapping the brain. This session will focus on cutting edge research in neural biomaterials including fundamental material development through pre-clinical studies. These include big questions surrounding diseases and injuries of the peripheral and central nervous systems spanning neurons, astrocytes, oligodendrocytes, microglia, and Schwann cells.
Moderators:
Sarah Stabenfeldt, PhD
Shelly Sakiyama-Elbert, PhD
Kyle Lampe, PhD
Abstracts
Abstracts will be available for download on April 20, 2021.
Immunomodulatory Biomaterials 2
Timeslot: Friday, April 23, 2021 - 11:00am to 12:30pm
Track: Immunomodulatory Biomaterials
Room: Virtual
About
The session will focus on engineered biomaterials for therapeutic immune modulation. Specifically, the session will cover topics ranging from biomaterials for delivery of immunomodulators and imaging agents, scaffolds for immunomodulation, cellâ€based therapies, etc. Several cutting edge immune engineering platforms will be included.
Moderator:
Ashish Kulkarni, PhD
Abstracts
Abstracts will be available for download on April 20, 2021.
Panel: Emerging Bionanomaterials and Nanotoxicity
Timeslot: Friday, April 23, 2021 - 11:00am to 12:30pm
Room: Virtual
About
The current pandemic has reminded us the challenges and difficulties in dealing with infections and other biomedical problems. Nanomaterials have found numerous applications in the field of medicine but are not without limitations. In this panel, the emerging and advancement of new nanomaterials, nanotoxicity, and their biomanufacturing will be presented, and their roles in potential COVID-19 diagnosis, treatments, and vaccine development will be discussed. Biomaterials like peptides will be used as examples to understand and control immune responses in developing vaccines or serving as innovative new nanomaterials.
Moderators:
Bingyun Li, PhD
J. Amber Jennings, PhD
Abstracts
Abstracts will be available for download on April 20, 2021.
Invited Speaker(s)
Targeted and Stimuli-Responsive Biomaterials for Drug Delivery - 2
Timeslot: Friday, April 23, 2021 - 11:00am to 12:30pm
Track: Functional Biomaterials and Surfaces
Room: Virtual
About
Targeted and stimuli-responsive biomaterials, are promising for various applications in drug delivery. These "smart" materials can act rapidly at the site of interest while avoiding biological barriers, toxicity, and other potential detrimental effects. Many stimuli have been utilized to trigger stimuli-responsive materials including pH, temperature, ionic strength, chemical and/or mechanical microenvironment, redox potential, and light. Similarly, many targeting mechanisms ranging from passive (e.g., enhanced permeation and retention) to active targeting approaches (e.g., peptide ligands) have been integrated into targeted drug delivery systems. This session will focus on the development and use of such materials for applications including, but not limited to, cancer, infection, orthopedic diseases, cardiovascular disease, and autoimmune diseases.
Moderator:
Anita Shukla, PhD
Abstracts
Abstracts will be available for download on April 20, 2021.
Tissue Engineering SIG - 2
Timeslot: Friday, April 23, 2021 - 11:00am to 12:30pm
Track: Tissue Engineering and Regenerative Medicine
Room: Virtual
About
Tissue Engineering SIG is a forum to exchange information, further knowledge, and promote greater awareness regarding all aspects of the use of biomaterials to engineering tissue substitutes or to promote tissue regeneration. Of primary interest and relevance to TE SIG is the use of appropriate materials (synthetic and natural) with cells (either native or from a donor source) and/or biological response modifiers (e.g., growth factors, cytokines and other recombinant products) to replace tissue and organ functions. Particular emphasis is placed on the development of materials to better incorporate, protect, and deliver both the cells and biological response modifiers to help promote the healing and regenerative processes. The group is committed to forging interactions among basic scientists, applied scientists, engineers, clinicians, industrial members, professional societies in related fields, and regulatory groups in its efforts to expand and effectively utilize the shared knowledge base in this multidisciplinary field.
Moderators:
Jeff Jacot, PhD
Ngan Huang, PhD
Abstracts
Abstracts will be available for download on April 20, 2021.